|
2977
|
Toloxatone
|
Reversible MAO-A inhibitor; Antidepressant |
€80.00 |
|
3993
|
Tolcapone
|
Potent, selective, orally active and reversible COMT inhibitor |
€70.00 |
|
2072
|
Tofacitinib citrate
|
Potent Janus Kinase 3 (JAK3) inhibitor |
€115.00 |
|
3624
|
Toceranib phosphate
|
Multi-targeted receptor tyrosine kinase inhibitor |
€60.00 |
|
3865
|
TNO155
|
Selective and orally bioavailable allosteric inhibitor of SHP2 |
Inquire |
|
4270
|
TNG-260
|
First-in-class, orally active, potent, and CoREST-selective deacetylase inhibitor |
Recently added
|
Inquire |
|
2628
|
TMS
|
CYP1B1 inhibitor that induces apoptosis in human cancer cells |
€75.00 |
|
2180
|
TMP 195
|
HDAC inhibitor (class IIA selective) |
€110.00 |
|
1507
|
TMI 005
|
TACE/MMP inhibitor |
€150.00 |
|
4111
|
TMDJ-035
|
First highly potent and selective RyR2 inhibitor |
€130.00 |
|
4213
|
TMDJ-011
|
Inactive analogue of TMDJ-035 |
€120.00 |
|
3966
|
TM30089 sodium
|
Selective CRTH2 antagonist |
Inquire |
|
3486
|
TM-N1324
|
Highly potent and selective GPR39 agonist |
€110.00 |
|
2734
|
TM 5441
|
Orally active inhibitor of PAI-1 |
€105.00 |
|
2344
|
TM 5275
|
Selective and orally active inhibitor of PAI-1 |
€105.00 |
|
3099
|
TL02-59
|
Potent, selective and orally active Fgr and Lyn inhibitor |
€120.00 |
|
1060
|
TL 99 hydrobromide
|
Dopamine agonist |
€95.00 |
|
1005
|
TL 232 hydrobromide
|
Dopamine agonist |
€95.00 |
|
1004
|
TL 102 hydrobromide
|
Dopamine agonist |
€95.00 |
|
3076
|
TJ191
|
Potent and selective anti-cancer agent targeting low TβRIII-expressing malignant T-cell leukemia/lymphoma cells |
€120.00 |
|
3497
|
Tizanidine hydrochloride
|
Centrally acting α2 adrenoceptor agonist |
€90.00 |
|
1717
|
Tivozanib
|
VEGFR1, 2, and 3 tyrosine kinase inhibitor |
€80.00 |
|
1383
|
Tiplaxtinin
|
Plasminogen activator inhibitor-1 (PAI-1) inhibitor |
€70.00 |
|
1518
|
Timolol maleate
|
β1 adrenergic antagonist |
€80.00 |
|
1913
|
Timapiprant
|
Selective DP2 (CRTH2) antagonist |
€90.00 |
|
2560
|
Tilfrinib
|
Brk inhibitor with antiproliferative activity in breast tumor cells |
€95.00 |
|
1564
|
Tienilic Acid
|
CYP2C10 Inhibitor |
€75.00 |
|
3579
|
Tideglusib
|
GSK-3 inhibitor |
€60.00 |
|
3111
|
Ticagrelor
|
Selective, reversible and orally available P2Y12 antagonist |
€60.00 |
|
3402
|
THZ531
|
First-in-class, potent, selective, covalent CDK12/CDK13 inhibitor |
€130.00 |